1,340
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Combined trans-arterial embolisation and microwave ablation for the treatment of large unresectable hepatic metastases (>3 cm in maximal diameter)

, , , , , & show all
Pages 1395-1403 | Received 08 Apr 2020, Accepted 03 Nov 2020, Published online: 21 Dec 2020

References

  • Kagawa T, Koizumi J, Kojima S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma comparison with surgical resection. Cancer. 2010;116:3638–3644.
  • Chiang J, Hynes K, Brace CL. Flow-dependent vascular heat transfer during microwave thermal ablation. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2012 Aug 28–Sep 1; San Diego, CA. 2012.
  • Flanders VL, Gervais DA. Ablation of liver metastases: current status. J Vasc Interv Radiol. 2010;21:S214–S222.
  • Ryan MJ, Willatt J, Majdalany BS, et al. Ablation techniques for primary and metastatic liver tumors. World J Hepatol. 2016;8:191–199.
  • Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280:949–959.
  • Vogl TJ, Zangos S, Eichler K, et al. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol. 2007;17:1025–1034.
  • Liu C, Liang P, Liu F, et al. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia. 2011;27:654–662.
  • Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci. 2013;58:2107–2113.
  • Lloyd DM, Lau KN, Welsh F, et al.; International Microwave Tumour Ablation Group (IMTAG). International multicentre prospective study on microwave ablation of liver tumours: preliminary results. HPB (Oxford). 2011;13:579–585.
  • Morimoto M, Numata K, Kondou M, et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer. 2010;116:5452–5460.
  • Knavel EM, Green CM, Gendron-Fitzpatrick A, et al. Combination therapies: quantifying the effects of transarterial embolization on microwave ablation zones. J Vasc Interv Radiol. 2018;29:1050–1056.
  • Fong ZV, Palazzo F, Needleman L, et al. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver. Am Surg. 2012;78:1243–1248.
  • Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202.
  • AMICA. Aparatus for Microwawe Ablation.pdf [Internet]. [cited 2020 May 29]. Available from: http://www.mermaidmedical.dk/PDF/Norway/9_Thermoablation/AMICA%20Aparatus%20for%20Microwawe%20Ablation.pdf
  • Hoffmann R, Rempp H, Erhard L, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology. 2013;268:89–97.
  • Shibata T, Isoda H, Hirokawa Y, et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905–913.
  • Murakami T, Ishimaru H, Sakamoto I, et al. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol. 2007;30:696–704.
  • Bonomo G, Della Vigna P, Monfardini L, et al. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol. 2012;35:1372–1379.
  • Peng Z-W, Chen M-S. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Oncology. 2013;84 Suppl 1:40–43.
  • Kim JH, Won HJ, Shin YM, et al. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18:1624–1629.
  • Seki T, Tamai T, Nakagawa T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. 2000;89:1245–1251.
  • Lee IJ, Kim YI, Kim KW, et al. Radiofrequency ablation combined with transcatheter arterial embolisation in rabbit liver: investigation of the ablation zone according to the time interval between the two therapies. Br J Radiol. 2012;85:e987–e994.
  • Konopke R, Roth J, Volk A, et al. Colorectal liver metastases: an update on palliative treatment options. J Gastrointestin Liver Dis. 2012; Mar;21:83–91.
  • Nakai M, Sato M, Sahara S, et al. Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol. 2007;13:2841–2845.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
  • Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89:1003–1007.
  • Livraghi T, Meloni F, Solbiati L, et al.; Collaborative Italian Group using AMICA system. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35:868–874.
  • Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72 Suppl 1:124–131.
  • Miyayama S, Yamashiro M, Okuda M, et al. Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol. 2010;21:1226–1234.
  • Huppert P. Current concepts in transarterial chemoembolization of hepatocellular carcinoma. Abdom Imaging. 2011;36:677–683.
  • Liu Y, Zheng Y, Li S, et al. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol. 2013;68:21–26.
  • Lang EK, Brown CL. Colorectal metastases to the liver: selective chemoembolization. Radiology. 1993;189:417–422.
  • Kettenbach J, Stadler A, Katzler IV, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol. 2008;31:468–476.
  • Wang Z-J, Wang M-Q, Duan F, et al. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas. WJG. 2013;19:4192–4199.
  • Alexander ES, Mick R, Nadolski GJ, et al. Combined chemoembolization and thermal ablation for the treatment of metastases to the liver. Abdom Radiol (NY). 2018;43:2859–2867.
  • Chiang J, Cristescu M, Lee MH, et al. Effects of microwave ablation on arterial and venous vasculature after treatment of hepatocellular carcinoma. Radiology. 2016;281:617–624.
  • Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661–669.